Literature DB >> 24084425

[First-episodes psychosis: clinical and epidemiological news].

M Tournier1.   

Abstract

In the context of the development of early intervention for first-episode psychosis, this manuscript reviews new data with respect to its incidence, risk factors and evolution. Annual incidence of non-affective psychosis appeared to be between 14 and 30/100,000 in people aged 18-64. Incidence decreases with age and is twice higher in men than in women. There is an interaction between age and gender; the risk of psychosis decreases with age faster in men than in women. Thus, for schizophrenia, incidence rate is twice higher in men under 45 year-old and similar in both genders after. There is evidence that genetic and environmental factors may cause enduring liability to psychotic disorder, and, in addition, that genes and environment may interact synergistically. Some environmental factors have been identified; they concern foetal life, childhood or adolescence and may be conceptualized at the individual or the contextual level. The definition of recent onset psychosis may be based on duration of psychosis, between two and five years. Its development is identified through the occurrence of major psychotic symptoms, such as positive, negative symptomatology or disorganization, and impairment of social functioning. The types and patterns of occurrence and of evolution of psychotic symptoms have a prognostic impact. A long duration of untreated psychosis impacts symptomatology. It is associated with less severe positive symptoms at baseline and more severe after three years, insidious onset, male gender, early onset, and diagnosis of schizophrenia. Recent onset psychosis is often associated with comorbidities, such as depression, anxiety disorders, suicidal behaviours, and addiction. Symptomatic remission rates are found between 25 and 60%. Symptomatic and functional remissions favour each other. A third to half of patients is active, employed or students. Symptoms and evolution are various in studies, probably corresponding to various patho-physiological mechanisms.
Copyright © 2013 L’Encéphale. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Incidence; Prognosis; Pronostic; Recent onset psychosis; Remission; Risk factors; Rémission; Trouble psychotique débutant; Étiologie

Mesh:

Year:  2013        PMID: 24084425     DOI: 10.1016/S0013-7006(13)70099-X

Source DB:  PubMed          Journal:  Encephale        ISSN: 0013-7006            Impact factor:   1.291


  3 in total

1.  Integrated treatment of first episode psychosis with online training (e-learning): study protocol for a randomised controlled trial.

Authors:  Sara Barbeito; Patricia Vega; Sonia Ruiz de Azua; Vicent Balanza-Martinez; Francesc Colom; Esther Lorente; Ana Luengo; Ester Cerrillo; José Manuel Crespo; Ana González Pinto
Journal:  Trials       Date:  2014-10-27       Impact factor: 2.279

2.  Acute psychosis in children: do not miss immune-mediated causes.

Authors:  Afnan S AlHakeem; Mohamed S Mekki; Saad M AlShahwan; Brahim M Tabarki
Journal:  Neurosciences (Riyadh)       Date:  2016-07       Impact factor: 0.906

Review 3.  Neuroimmune Interactions in Schizophrenia: Focus on Vagus Nerve Stimulation and Activation of the Alpha-7 Nicotinic Acetylcholine Receptor.

Authors:  Fabiana Maria das Graças Corsi-Zuelli; Fernanda Brognara; Gustavo Fernando da Silva Quirino; Carlos Hiroji Hiroki; Rafael Sobrano Fais; Cristina Marta Del-Ben; Luis Ulloa; Helio Cesar Salgado; Alexandre Kanashiro; Camila Marcelino Loureiro
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.